COVID-19 Notice: We are providing FREE consultations via phone or video conferencing for your safety and convenience. Learn More »
Published on:

Drug Recall Lawyer Blog Round-Up

Here are this week’s stories:

  • FDA: Little progress on more FDA independence and power in drug safety reviews (An appropriate lament by Tom Lamb).
  • Heparin: Congressional examination into the contaminated Heparin debacle (HT: FiercePharma).
  • Tylenol Recall: Seems we just went through this. Here’s another one, affecting infant/children Tylenol, Motrin, Zyrtec and Benadryl.
  • Pain Pumps: Drug and Device Law Blog’s view of the recent MDL denial.

Happy Monday!